Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD8+ T Cell Expression in Lung Cancer

被引：0
|
作者：
Jin, Yasuto
Matsubara, Osamu
Yamanaka, Kazuki
Mark, Eugene
机构：
[1] Kyosai Hosp, Hiratsuka, Kanagawa, Japan
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1935
引用
收藏
页码：481A / 481A
页数：1
相关论文
共 50 条
  • [1] Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD8+ T Cell Expression in Lung Cancer
    Jin, Yasuto
    Matsubara, Osamu
    Yamanaka, Kazuki
    Mark, Eugene
    LABORATORY INVESTIGATION, 2017, 97 : 481A - 481A
  • [2] Intratumoral programmed cell death-ligand 1 (PD-L1) and Intratumoral CD8+T cell Expression in Lung Cancer
    Jin, Yasuto
    Yamauchi, Shuta
    Shimada, Hiroyuki
    Matsubara, Osamu
    CANCER SCIENCE, 2018, 109 : 1099 - 1099
  • [3] Expression of intratumoral programmed cell death-ligand 1 (PD-L1) and intratumoral CD8+T cell and FOXP3+T cell in lung cancer
    Jin, Yasuto
    Imase, Reina
    Shimada, Hiroyuki
    Yamauchi, Shuta
    Matsubara, Osamu
    LABORATORY INVESTIGATION, 2018, 98 : 735 - 735
  • [4] Expression of intratumoral programmed cell death-ligand 1 (PD-L1) and intratumoral CD8+T cell and FOXP3+T cell in lung cancer
    Jin, Yasuto
    Imase, Reina
    Shimada, Hiroyuki
    Yamauchi, Shuta
    Matsubara, Osamu
    MODERN PATHOLOGY, 2018, 31 : 735 - 735
  • [5] Expression of Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD4+T Cell, CD8+T Cell and FOXP3+T Cell in Lung Cancer
    Jin, Y.
    Shimada, H.
    Yamauchi, S.
    Inase, N.
    Matsubara, O.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S731 - S731
  • [6] Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer
    Govindarajan, Rangaswamy
    Gujja, Swetha
    Siegel, Eric R.
    Batra, Anu
    Saeed, Anwaar
    Lai, Keith
    James, Jennifer D.
    Fogel, Bradley J.
    Williamson, Stephen
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (07): : 638 - 642
  • [7] Expression of intratumoral PD-L1 and intratumoral CD4+T cell, CD8+T cell, and FOXP3+T cell in lung cancer
    Shimada, Hiroyuki
    Yamauchi, Shuta
    Jin, Yasuto
    CANCER SCIENCE, 2018, 109 : 1410 - 1410
  • [8] Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC)
    Abbas, M.
    Steffens, S.
    Bellut, M.
    Eggers, H.
    Grosshennig, A.
    Becker, J. U.
    Wegener, G.
    Schrader, A. J.
    Gruenwald, V.
    Ivanyi, P.
    MEDICAL ONCOLOGY, 2016, 33 (07)
  • [9] Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC)
    M. Abbas
    S. Steffens
    M. Bellut
    H. Eggers
    A. Großhennig
    J. U. Becker
    G. Wegener
    A. J. Schrader
    V. Grünwald
    P. Ivanyi
    Medical Oncology, 2016, 33
  • [10] Intratumoral Heterogeneity of Programmed Cell Death Ligand-1 (PD-L1) Expression in Lung Cancers - Assessment by Spiral Array
    Nakamura, Sayuri
    Hayashi, Kentaro
    Imaoka, Yuki
    Kitamura, Yuka
    Akazawa, Yuko
    Groen, Ruben
    Nagayasu, Takeshi
    Yamasaki, Naoya
    Tuchiya, Tomoshi
    Fukuoka, Junya
    LABORATORY INVESTIGATION, 2017, 97 : 486A - 486A
12345